Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHRP-1/AG in ESRD on Hemodialysis
NCT00381602Phase 2Terminated
- Sponsor
- QLT Inc.
- Start
- Sep 2006
- Primary completion
- May 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Growth hormone-releasing peptide 1 in Malnutrition (2 arms), sponsored by QLT Inc. Primary endpoints: Malnutrition Inflammation Score, Caloric Intake and 4 more. Started Sep 2006; status: terminated.
02
Drugs
Growth hormone-releasing peptide 1
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT00381602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381602.